We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$237M
AUM Growth
-$13.8M
Cap. Flow
-$6.52M
Cap. Flow %
-2.75%
Top 10 Hldgs %
59.31%
Holding
121
New
11
Increased
20
Reduced
8
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 32.15%
2 Industrials 13.86%
3 Technology 10.97%
4 Consumer Discretionary 9.86%
5 Energy 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HHH icon
26
Howard Hughes
HHH
$3.87B
$1.61M 0.68%
13,637
-13,532
-50% -$1.39M
QTNT
27
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.59M 0.67%
4,250
STML
28
DELISTED
Stemline Therapeutics, Inc.
STML
$1.54M 0.65%
100,634
-57,161
-36% -$827K
AB icon
29
AllianceBernstein
AB
$3.43B
$1.5M 0.63%
50,500
CELG
30
DELISTED
Celgene Corp
CELG
$1.47M 0.62%
15,847
+10,880
+219% +$1.03M
CHRS icon
31
Coherus Oncology
CHRS
$218M
$1.38M 0.58%
62,387
+21,918
+54% +$381K
CPRX
32
DELISTED
Catalyst Pharmaceutical
CPRX
$1.32M 0.56%
343,347
-167,500
-33% -$724K
BMY icon
33
Bristol-Myers Squibb
BMY
$136B
$1.23M 0.52%
27,080
+21,652
+399% +$1.01M
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.2M 0.51%
50,046
+2,206
+5% +$56K
AIMT
35
DELISTED
Aimmune Therapeutics
AIMT
$1.2M 0.5%
57,456
+2,400
+4% +$49.4K
INDP icon
36
Indaptus Therapeutics
INDP
$152M
$1.13M 0.48%
116
-14
-11% -$177K
APC
37
DELISTED
Anadarko Petroleum
APC
$1.13M 0.48%
15,960
ARNA
38
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.07M 0.45%
18,332
-18,344
-50% -$948K
VZ icon
39
Verizon
VZ
$208B
$1.05M 0.44%
18,311
JNJ icon
40
Johnson & Johnson
JNJ
$646B
$1.01M 0.43%
7,280
RHP icon
41
Ryman Hospitality Properties
RHP
$8.92B
$1M 0.42%
12,400
FNM.PRT
42
DELISTED
FEDERAL NATL MTG ASS 08250
FNM.PRT
$996K 0.42%
+85,000
New +$996K
DD icon
43
DuPont de Nemours
DD
$18.5B
$942K 0.4%
9,994
-4,871
-33% -$582K
XRN.PRA
44
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$78.1M
$918K 0.39%
35,000
FOMX
45
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$883K 0.37%
371,046
+24,700
+7% +$73.8K
CNQ icon
46
Canadian Natural Resources
CNQ
$101B
$873K 0.37%
66,059
MDLZ icon
47
Mondelez International
MDLZ
$79.6B
$857K 0.36%
15,900
ABBV icon
48
AbbVie
ABBV
$451B
$808K 0.34%
11,100
+6,100
+122% +$479K
EPRT icon
49
Essential Properties Realty Trust
EPRT
$6.57B
$802K 0.34%
40,000
KMB icon
50
Kimberly-Clark
KMB
$36.4B
$800K 0.34%
6,000

Similar funds

David M. Knott's Q2 2019 Portfolio in Review

As of Q2 2019, David M. Knott held 121 positions worth $237M, down 5.5% from $251M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

David M. Knott's Q2 2019 filing shows 11 new, 20 increased, 8 reduced and 10 closed positions. Its largest new stake was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K. The largest sale was Capitol Federal Financial, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.

  • David M. Knott's largest Q2 2019 buy was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K.
  • David M. Knott added most to Brightstar Lottery PLC in Q2 2019, an estimated $6.7M increase.
  • David M. Knott's biggest Q2 2019 reduction was Capitol Federal Financial, cutting an estimated $8.97M.
  • David M. Knott fully exited Oracle in Q2 2019, selling an estimated $8.06M.
  • David M. Knott's ten largest holdings make up 59% of its $237M portfolio in Q2 2019.
  • David M. Knott opened 11 new positions and closed 10 in Q2 2019.
  • David M. Knott's portfolio value fell 5.5% quarter-over-quarter to $237M.

Based on David M. Knott's 13F filing for Q2 2019, filed 12 Aug 2019.